Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLN9708 plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma (China)
CTR20130908Phase 3Active
- Sponsor
- Millennium Pharmaceuticals
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ixazomib in multiple myeloma (MM), sponsored by Millennium Pharmaceuticals. Started Apr 2014; status: active.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20130908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130908.